Back to search results

SleepSMART for Veterans with Insomnia and Mild Cognitive Impairment

This study is testing two behavioral therapies, Cognitive Behavioral Therapy for Insomnia (CBT-I) and SleepSMART, for Veterans who have both insomnia and mild cognitive impairment (MCI). SleepSMART is a version of CBT-I specifically designed to help older Veterans with memory issues learn and stick with the treatment. The goal is to see if these treatments can improve insomnia symptoms. You might be able to join if you are a Veteran aged 60 or older, have a diagnosis of MCI and insomnia, and can understand English. The study will measure success by looking at changes in your insomnia symptoms over time. The current status of this study is unclear.

Study design
This interventional study plans to enroll 150 participants. It compares two behavioral therapies: CBT-I and SleepSMART.
What's involved
You would participate in 6 weekly sessions for either CBT-I or SleepSMART. Your insomnia symptoms will be measured at the start, after treatment, and 3 months later.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after treatment, with a final assessment at week 20.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07397182

SleepSMART for Veterans With Insomnia and Mild Cognitive Impairment

Not Yet Recruiting
NAAges 60+InterventionalTreatment
VA Office of Research and Development
~150 participants
Updated 2026-07-23 on ClinicalTrials.gov
What's tested:Cognitive BehavioralTherapy for Insomnia (CBT-I)SleepSMART

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Insomnia Severity Index (ISI)
Measured over Pre-treatment (week 1), post-treatment (week 8), and 3-month follow up (week 20)

Conditions

Insomnia
Mild Cognitive Impairment

Explore related trials

InsomniaMild cognitive disorder

NCT07397182

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • VA San Diego Healthcare System, San Diego, CA

    San Diego, Californiastudy coordinator listed

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Erin Almklov, PhD · PRINCIPAL_INVESTIGATOR · VA San Diego Healthcare System, San Diego, CA

Who to contact

Erin Almklov, PhD
[email protected]
(858) 855-8585 · ext. 2345
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Veterans
chart diagnosis MCI
DSM-5 diagnosis of insomnia and an Insomnia Severity Index (ISI) score \>7 at baseline
ability to understand, speak, and read English with acceptable visual and auditory acuity
stable on medications for at least 4 weeks prior to enrollment

Exclusion

presence of neurological disorders such as Parkinson's disease or seizures, dementia (based on chart diagnosis or clear evidence of dementia at the baseline neuropsychological testing using DSM5 criteria for Major Neurocognitive Disorder)
and/or history of moderate to severe TBI (determined by medical record or self-report of \>30 minutes loss of consciousness)
schizophrenia, psychotic disorder, and/or bipolar disorder
untreated or poorly managed medical conditions that may impact sleep, including thyroid disease, nocturia, chronic respiratory or heart disease, or diabetes
untreated obstructive sleep apnea and/or sleep disturbances other than insomnia
current substance use disorder with \<30 days abstinence
suicidality greater than mild risk as measured by the Columbia-Suicide Severity Rating Scale
exposure to therapist directed (individual or group) CBT-I within the past year

What this trial measures

  • Insomnia Severity Index (ISI)Pre-treatment (week 1), post-treatment (week 8), and 3-month follow up (week 20)

    Pre-treatment (week 1), post-treatment (week 8), and 3-month follow up (week 20) scores on the ISI will be compared.